Recent advances in the development of RIPK2 modulators for the treatment of inflammatory diseases

Overview of attention for article published in Frontiers in Pharmacology, March 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 11,482 followers.

RT @FrontPharmacol: New Research: Recent advances in the development of RIPK2 modulators for the treatment of inflammatory diseases https:/…

RT @FrontPharmacol: New Research: Recent advances in the development of RIPK2 modulators for the treatment of inflammatory diseases https:/…

RT @FrontPharmacol: New Research: Recent advances in the development of RIPK2 modulators for the treatment of inflammatory diseases https:/…

RT @AstatinePham: NODs/RIPK2 signaling pathway plays pivotal roles in immunity. Our new review on RIPK2 inhibitors and degraders is online.…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.